milsaperidone (Bysanti)

From Aaushi
Jump to navigation Jump to search

Indications

Pharmacokinetics

Mechanism of action

References

  1. Monaco K New Pill Approved for Schizophrenia, Bipolar Disorder. Milsaperidone is an active metabolite of iloperidone. MedPage Today. February 23, 2026 https://www.medpagetoday.com/psychiatry/bipolardisorder/120004